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Introduction {#sec1}
============

Given that the basic genome of a differentiated organism is constant between cells (and we here ignore epigenomics), what mainly discriminates one cell type from another is its expression profile. The "surfaceome" (those proteins expressed on the cell surface) attracts our interest in particular, as it contains the transporters that determine which nutrients (and xenobiotics such as drugs) are taken up by specific cells ([@bib17], [@bib70]). Transporters are the second largest component of the membrane proteome ([@bib2]), and also a (surprisingly) understudied clade ([@bib13]). They are classified into solute carriers (SLCs) ([@bib16], [@bib25], [@bib35], [@bib72], [@bib80], [@bib83]), mainly involved in uptake, and ABC transporters (ABCs), mainly involved in efflux (e.g., [@bib14], [@bib22], [@bib59], [@bib76]).

Transporters are also responsible for the uptake of pharmaceutical drugs and xenobiotics into cells, and their efflux therefrom ([@bib16], [@bib20], [@bib26], [@bib27], [@bib41], [@bib42], [@bib44], [@bib43], [@bib46], [@bib56], [@bib84]). This means that, to understand drug distributions, we must understand transporter distributions. In many cases, we do not know either the "natural" ([@bib64], [@bib66], [@bib72]) or the pharmaceutical drug substrates of these transporters, and one clue to this may be to understand transporters\' differential tissue distribution.

In the present work we used absolute transcription profiles acquired (via RNA sequencing) as part of the tissue atlas ([@bib90]) and cell atlas ([@bib86]). Altogether there are four main datasets, namely 409 SLCs in 59 tissue types and 56 cell lines, and 48 ABCs in the same tissue types and cell lines. Some of the SLCs do not (yet) have the official terminology ([@bib72], [@bib83]), but, based on a variety of phylogenetic and other evidence, as well as their UniProt annotations, they clearly have this function, and these are noted accordingly. Similarly, some of the "ABC" families (especially family F) are probably not functionally membrane transporters, but they are nonetheless included.

The availability of extensive and high-quality transcriptomic datasets allows us to develop a series of novel analyses. They are necessarily illustrative, but by making the data available in a convenient form, we think that readers will be encouraged to make their own analyses of other aspects. In particular, the Gini index serves to highlight unusual features of the biology of a great many transcripts; we refer to this strategy of using the Gini index to analyze expression profiling data as GeneGini.

A preprint has been deposited at bioRxiv ([@bib65]).

Results {#sec2}
=======

Gini Index {#sec2.1}
----------

Our first interest was to provide a convenient method for summarizing the variation in gene expression profiles in different samples (in this case different tissues and cell lines). A variety of means exist to capture variation; however, none of the more common statistical measures captures the full range well, especially including the many zeroes (undetectable expression levels). One that does is the Gini index ([@bib12], [@bib28], [@bib29]) or Gini coefficient (GC). This is a non-parametric measure that is widely used in economics to describe distributions of incomes between individuals in a given group or political jurisdiction (e.g., country or region) ([@bib51], [@bib74], [@bib94]). As a summary statistic of the entire Lorenz curve ([@bib54]) (see [Figure 1](#fig1){ref-type="fig"}), it is a statistical measure of the degree of variation represented in a set of values. It ranges between 0 (no variation) and 1 (extreme variation, in which all non-zero values are contained in one individual or example). Clearly it can be used to describe the distribution of anything else, e.g., the structural diversity in chemical libraries ([@bib93]) (modulo; [@bib64]). It has very occasionally been used in gene expression profiling studies ([@bib1], [@bib40], [@bib87], [@bib88]). However, in each of these latter cases, including a very recent and nicely done example on cancer cell susceptibility to drugs ([@bib81]), where it varied from 0.05 to 1, the Gini index was used for choosing subsets of transcripts that differentiate rare cell types or diseases. Here we *know* the cell types, and the novelty of GeneGini lies in using the Gini index to assess individual genes in terms of the uniqueness of their expression levels. A more intuitive, graphical illustration is given in [Figure 1](#fig1){ref-type="fig"}A.Figure 1Overall Assessment of Variation in Gene Expression Profiles(A) The Gini index. Many equivalent definitions are possible. In the usual form, the Gini coefficient is defined mathematically based on the Lorenz curve, which plots the proportion of the total income or wealth of a population (ordinate) that is earned cumulatively by the bottom x% of the population (see diagram) as x increases. Here "income" is the percentage of total transcripts, while the "population" is the individual transporter transcripts considered at one time. (The same general form results if the abscissa is reversed, starting with the top earners, where it takes on the appearance of the more familiar receiver-operator characteristic curve or ROC curve; [@bib4], [@bib7], [@bib57].) The line at 45° represents uniform expression of each transcript. The Gini coefficient can then be seen as the ratio of the area that lies between the line of equality and the Lorenz curve (labeled A in the figure) to the total area under the line of equality (labeled A and B), i.e., G = A/(A + B).(B) Median and maximum expression levels (ignoring those with undetectable expression even at the median) in the 59 tissues considered.(C) Gini coefficient for the expression of all SLCs in 59 tissues; those with Gini coefficients above 0.9 or below 0.25 are shown.(D) SLC25A31 is almost exclusively expressed in the testes (the expression levels for others being 100 times less).(E) SLCO1B1 is almost exclusively expressed in the liver (with the expression level in other tissues being 100 times lower or less).(F) Antibody-based expression of the SLC22A12, SLC6A18, and SLC2A14 transporters in kidney, testis, and liver tissues. SLC22A12 and SLC6A18 are expressed in renal proximal tubules, whereas SLC2A14 is expressed in cells in seminiferous ducts. Image edge length is 320 μm.

### Variation in Expression Profiles of SLCs in Tissues {#sec2.1.1}

As is typical in exploratory data analysis ([@bib89]), we begin with the following general comments (the full datasets are given in Supplemental Information: [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}):(1)The variation of transporter expression levels between different tissues or cell lines is very far from being normal (Gaussian) (see [@bib7] for methods; data not shown). The extreme here (and see below) is probably SLCO1B1 ([@bib32]), whose expression is virtually confined to the liver alone (a fact that has been exploited effectively for drug targeting purposes \[[@bib73]\]);(2)The tissue with the maximum overall expression of transporters (SLC and/or ABCs) is the kidney (Σ10,950); that with the fewest is the pancreas (Σ1,490);(3)The SLCs with, overall, the greatest expression in total are SLC6A15 (a neutral amino acid transporter \[[@bib75]\]), whose activity has been implicated in depression ([@bib50]), and SLC25A3 (a mitochondrial phosphate transporter \[[@bib71]\]), while that least expressed *in toto* is SLC6A5 (glycine transporter).(4)Almost every transporter ranges in its expression by over two orders of magnitude in different tissues, and several by more than three or even four orders of magnitude (see also [@bib83], [@bib95]).(5)The heatmap of expression levels shows a number of major co-expression clusters.

[Figure S1](#mmc1){ref-type="supplementary-material"} shows the minimum and maximum expression levels (as TPM \[transcripts per million\]) for each transporter, with the top 20 (maximum expressions) labeled explicitly. Open circles are those not explicitly labeled as SLC family members. Interestingly, the mitochondrial transporters ([@bib71]) SLC25A3 (for phosphate) and SLC25A5 (for adenine nucleotide translocase \[[@bib15]\]) are among the most highly expressed, as is the non-SLC MTCH1, which, as its name implies, is a mitochondrial carrier homologue. The co-expression of SLC25A3 and SLC25A5 is entirely logical (not shown, but see data files), as ATP synthesis and export require the transport of equimolar amounts of its substrates. Many other SLC25 (mitochondrial transporter) family members are well represented as high expressers in at least one tissue. Note that expression levels below 0.01 TPM are not shown. [Figure 1](#fig1){ref-type="fig"}B shows similar data for the median versus the maximum expression in the different tissues, which again serves to highlight the considerable heterogeneity of expression. The median of the set of median expression levels for all the SLCs was 3.19 TPM. In addition, it is not at all the case that a transporter tends to be either highly expressed or weakly expressed; although as many transporters are widely distributed, there is a considerable degree of specialization (see also [@bib83]).

The Gini index for the variation in (inequality of distribution of) transporters ([Figure 1](#fig1){ref-type="fig"}C) is fully consistent with this, with a significant number having an exceptionally high value (66 at 0.9 or above), not least SLC22 family members, often in the kidney (see below), and with only 23/409 SLCs having a GC below 0.25. One interpretation is that, mostly, individual transporters may be quite specialized; another is that different tissues require different amounts of specific substrates, although such large differences are thereby not easily explained in general. The *median* GC for this overall class of SLCs and related transporters is 0.587. A number of those with the lowest GCs are again in the SLC25 (mitochondrial transporter) family; this is not unreasonable, since every cell is likely to have mitochondria, but some family members are clearly very specialized for particular mitochondria. Thus ([Figure 1](#fig1){ref-type="fig"}D) SLC25A31 (AAC4), a particular isoform of the adenine nucleotide translocase ([@bib71]), is essentially expressed only in the testes ([@bib21]) (GC = 0.965), a finding of unknown biological significance ([@bib34]). However, since its removal inhibits spermatogenesis ([@bib9]), and thus causes infertility ([@bib8]), it is potentially a target for the development of male contraceptives. Thus, SLCs with very high GCs may provide very tissue-specific targets.

SLCO1B1 (a major transporter of so-called statins) is confined essentially to expression only in the liver ([Figure 1](#fig1){ref-type="fig"}E), and its GC is ∼0.96. By contrast (GC = 0.188), transporters such as SLC35A4 are almost universally expressed at a similar level ([Figure S2](#mmc1){ref-type="supplementary-material"}). However, this is not true of all SLC35 family members, since SLC35F2 enjoys a very wide distribution of expression levels in both tissues ([Figure S3](#mmc1){ref-type="supplementary-material"}) and cell lines ([@bib95]). We also have an interest in the ergothioneine transporter (SLC22A4, previously known as OCTN1) ([@bib30]), as an example of a transporter that definitely favors the transport of an *exogenous* substrate ([@bib64]); [Figure S4](#mmc1){ref-type="supplementary-material"} shows its expression profile distribution in the tissues considered; its GC is 0.502. Finally, we illustrate ([Figure 1](#fig1){ref-type="fig"}F) the spatial expression of SLC22A12 (URAT1, a urate transporter) ([@bib49]) in the kidney, virtually the only tissue in which it shows expression (Gini index = 0.978). Biologically this implies that uric acid is to be seen more as a product than as a substrate here.

One hypothesis around transporters might be that major nutrient transporters ([@bib70]) might be more universally expressed, since such substrates are nominally available via the bloodstream to most tissues. However, this does not seem to hold up, and the GC again provides a convenient means of clarifying that. Thus, SLC6A18, a neutral amino transporter, has the 15th highest GC (0.955), and its expression is essentially confined to the kidney proximal tubule. Similarly, SLC2A14, a glucose transporter ([@bib60]), has a GC of 0.853 and is again largely confined to the testes ([Figure 2](#fig2){ref-type="fig"}I). [@bib60], however, comment that its physiological substrate is unknown, despite it having 95% sequence identity to the *SLC2A3* gene that definitely encodes a glucose transporter.Figure 2Clustering of (Co-)Expression Profiles of SLC Transporters(A) Significant correlation (in log-log space) between the expression profiles of SLC39A5 and SLC17A4 (r^2^ = 0.86).(B) Overall heatmap, with four major clusters highlighted.

### Correlations and Heatmaps {#sec2.1.2}

Some unexpected correlations arise, e.g., that between the expression of SLC39A5 (ZIP5, a Zn^2+^ transporter \[[@bib39]\]) and SLC17A4 (supposedly a sodium/phosphate transporter in the vesicular glutamate transport family, of unknown function \[[@bib77]\]; r^2^ = 0.86) ([Figure 2](#fig2){ref-type="fig"}A). Such findings raise many questions but provide few present answers. However, they do provide useful starting points for the testing of biological hypotheses. In this case, one might hypothesize that they are co-regulated, and indeed both are downregulated during a *Clostridium difficile* infection ([@bib11]).

Co-clustered heatmaps of expression levels provide a convenient visual summary of large amounts of data. Thus, [Figure 2](#fig2){ref-type="fig"}B shows the full heatmap for SLC expression in tissues. Although, as stated, all the data are provided in full ([Supplemental Information](#app1){ref-type="fn"}) to allow readers to explore them, we have marked four major clusters (zoomed in in [Figures S5--S8](#mmc1){ref-type="supplementary-material"}). With the exception of a slight preponderance of families SLC 25 and 35 in cluster 3 ([Figure S7](#mmc1){ref-type="supplementary-material"}) and of SLC35 in cluster 4 ([Figure S8](#mmc1){ref-type="supplementary-material"}), there was no obvious clustering at the level of families. This gives weight to the idea that SLC transporters have mainly exhibited *divergent* evolution ([@bib37]).

### SLCs in Cell Lines {#sec2.1.3}

[Figure 3](#fig3){ref-type="fig"}A shows the minimum non-zero versus maximum expression levels of SLCs in cell lines ([Figure 3](#fig3){ref-type="fig"}A). The trends are broadly similar, with some of the most highly expressed transporters again being SLC25A3, SLC25A5, MTCH1, and SLC3A2, although there are also differences. The overall spread seems broadly similar to those of tissues, with a preponderance of transporters having minima in the decade 1--10 TPM and maxima in the decade 20--200 TPM. In this sense, cell lines are a reasonable representation of the behavior of tissues. The number of SLCs with a GC over 0.9 is 70, while those with GCs below 0.25 is 35 ([Figure 3](#fig3){ref-type="fig"}B). These numbers and behaviors are also close to those for tissues. The median GC for SLCs in cell lines (0.595) is very close to that for tissues (0.587). We note that there may be a mixture of cell types in the tissues, and that some (or even many) transporters likely exhibit a cell-type-specific expression pattern such as SLC22A12, SLC6A18, and SLC2A14 ([Figure 2](#fig2){ref-type="fig"}I). Finally ([Figure 3](#fig3){ref-type="fig"}C) we show the extensive (4,000-fold) variation in expression profiles of SLC22A4 (the ergothioneine transporter) in the different cell lines, again illustrating very substantial differences in "need" for this exogenous antioxidant ([@bib33]) compound. Consistent with this, the cell line with the greatest expression is a skin cell line, that is normally exposed to atmospheric oxygen.Figure 3Expression Profiling of Various Transporters in 56 Cell Lines(A) Minimum and maximum expression levels (as in [Figure S1](#mmc1){ref-type="supplementary-material"} not showing those with undetectable expression) in the 56 cell lines considered.(B) Median and maximum expression levels (ignoring those with undetectable expression even at the median) in the 56 cell lines considered.(C) SLC22A4 expression levels (in TPM) in different cell lines.

### ABC Transporters in Tissues {#sec2.1.4}

[Figure 4](#fig4){ref-type="fig"}A shows the minimum and maximum expression levels for all 48 ABCs, many of which lack detectable expression in at least one tissue type. Again, the ranges of expression are considerable, but their expression levels tend to be slightly lower than those of the SLCs. The total numbers are small, but no family (encoded in color in [Figure 5](#fig5){ref-type="fig"}A), except possibly F, seems especially highly expressed. The overall most highly expressed ABC transporter is ABCC4. The GCs ([Figure 4](#fig4){ref-type="fig"}B) vary more than those of the SLCs, and have a median value of 0.496. Five of 48 GCs are greater than 0.9, while four are below 0.25. Several ABCs exhibit very high GCs, that (0.939) of ABCG5 being the largest; it is mainly expressed in the duodenum and the liver. Those of the F family, however, while highly expressed, also have a low GC, indicating that they tend to be among the more highly expressed in most tissues. Indeed, consistent with their being outliers, they are probably not in fact transporters (e.g., [@bib61]).Figure 4Expression Profiling of Various ABC Transporters in 59 Tissues and 56 Cell Lines(A) Minimum and maximum expression levels in the 59 tissues considered.(B) Gini coefficient for the expression of all ABC transporters in 59 tissues.(C) Minimum and maximum expression levels in the 56 cell lines considered.(D) Gini coefficient for the expression of all ABC transporters in 56 cell lines.Figure 5Overall Variance of SLC plus ABC Transporter Expression in Different Tissues, A, and Different Cell Lines, B(A and B) Analyses were run in KNIME using the expression profiles of both SLCs and ABCs, each normalized to unit variance. Inserts in (A and B) represent the scree plots of percent variance explained by different principal components (PCs).(C) Variance in transcript levels of both SLC (blue) and ABC (red) transporters in just two cell lines (BEWO and ASC/TERT1) (r^2^ = 0.50).

### ABC Transporters in Cell Lines {#sec2.1.5}

[Figure 4](#fig4){ref-type="fig"}C shows the minimum and maximum expression levels for all 48 ABCs, many of which lack detectable expression in at least one cell line. Again, the ranges of expression are considerable, and somewhat more so than those of the SLCs in tissues. No family (encoded in color in [Figure 4](#fig4){ref-type="fig"}C) seems especially highly expressed. The overall most highly expressed ABC transporter is ABCE1. The GCs ([Figure 4](#fig4){ref-type="fig"}D) are also larger and vary more than those of both the SLCs and of the ABCs in tissues, with a median value of 0.692, suggesting adaptive selection for specialized purposes in the relevant cell lines. Eleven of 48 GCs are greater than 0.9, while five are below 0.25. Several ABCs exhibit very high GCs, that (0.964) of ABCG5 (a sterol transporter \[[@bib48]\]) again being the largest; here it is effectively expressed only in the HepG2 liver carcinoma cell line.

Overall, the median expression levels for SLCs are 3.27 and 1.26 TPM for tissues and cell lines, respectively, while those for ABCs are 4.23 and 1.48 TPM. Thus, while many of these cell lines are cancer derived, the majority of differentially expressed genes (as transporters are) are downregulated in cancer cells ([@bib18]). By contrast, if (as helpfully pointed out by a referee) we consider maxima, the median of the maxima in cell lines is close to double that in tissues, both for SLCs (646 versus 368 TPM) and ABCs (98 versus 48 TPM). Thus some transporters are indeed substantially overexpressed in cancer cell lines.

Overall Analysis and Clustering of Cell Lines Based on Transporter Transcripts {#sec2.2}
------------------------------------------------------------------------------

Although the data are far from being normally distributed, it is of interest to see which tissues and cell lines are most different from each other based solely on the expression profiles of their transporters; these data (normalized to unit variance) are given as a principal components plot in [Figures 5](#fig5){ref-type="fig"}A and 5B, where tissue type is encoded by color, and in the former, whether it is a tumor (gray) or not, is also encoded by a circular shape. Only a small amount of the variance is explained by the first two principal components, consistent with the high variability between tissues and cells, and scree plots are given as insets. The cell line expressing the largest total amount of transporter transcripts (11,566 TPM) *in toto* is BeWo (a placental carcinoma), while that expressing the fewest (5,215 TPM) is ASC TERT1 (a human telomerase-immortalized human adipose-derived mesenchymal stem cell line); the variance in transcripts that may be observed between these two cell lines is given in [Figure 5](#fig5){ref-type="fig"}C, with several of those with the greatest differences illustrated. That the total variation in transporter expression is just 2-fold shows (1) the limitation of membrane "real estate" area that partly controls membrane protein expression ([@bib47]), and (2) their overall importance to the cellular economy.

Unusually Heterogeneous Nature of Cell Transporter Expression Profiles {#sec2.3}
----------------------------------------------------------------------

### Tissues {#sec2.3.1}

While the values of GC for the expression profiles of transporters between different tissues and cells tend to be unusually high, we have not yet quantified their differences relative to those of other genes.

From such data, the most transcribed gene over any other in cell lines is the *ATP6* gene (mitochondrial ATP synthase subunit a, UniProt [P00846](uniprotkb:P00846){#intref0010}, 42,706 TPM in HeLa cells), while that in tissues is *ALB* (albumin, UniProt [P02768](uniprotkb:P02768){#intref0015}, 105,947 TPM in liver). The median of all the maxima for tissues is 46 TPM, and for cell lines 40 TPM. Obviously the first of these (*ATP6* and *ALB*) are much larger numbers than those for any transporters ([Figures 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}), but the medians (see also [Figure 1](#fig1){ref-type="fig"}B) are in quite a similar range; this again illustrates the rather specialist nature of different tissue expression profiles.

The overall picture of the distribution of tissue GCs between the three classes of molecule (SLC/ABC/other) is given in [Figure 6](#fig6){ref-type="fig"} (422 genes had very little expression at all \[max = 0.25 TPM\] and were ignored). Gene names are in alphabetic order, so it is clear where most of the ABCs (in blue) and SLCs (red) lie. Simply by inspection of this figure we can tell that many more "other" genes (19%) have a GC below say 0.25 than those for SLCs (9%) and ABCs (10%). In a similar vein, 33% of SLCs and 24% of ABCs have a GC exceeding 0.75, while 24% do for other genes. This latter high number is because of several clusters that are visible (and marked) in [Figure 6](#fig6){ref-type="fig"}A, specifically those for olfactory receptor proteins (over 300 genes, expressed in specific tissues, which, given their high GCs, necessarily varied for different olfactory receptor proteins) and keratin (over 150 genes, mainly in the melanoma tissues, of which 58 are KRT for keratin and 58 KRTAP for keratin-associated proteins). Note, however, that the maximum expression level for most ORs, and for 69% of the 94 KRTAP (keratin-associated protein) genes, was mainly less than 1 TPM; it is thus uncertain whether they encode detectable levels of protein. By contrast, transcriptional activators in the form of zinc-finger proteins (over 500 transcripts, 82%/97% of which had a median/maximum expression greater than 1 TPM) have very low GCs as they seem to play regulatory roles in almost all cells. Cyclins are of interest, as these should be expressed only in dividing cells. Thus *CCNA1*, the gene for cyclin A1, has a GC of 0.844. However, because our focus here is on transporters, we shall not pursue all these other very interesting questions here.Figure 6Variation of Gini Coefficients of Different Protein Classes in 59 Tissues(A) All transcripts, alphabetically, in tissues.(B) Transcripts with a particularly low Gini coefficient in tissues.(C) Inverse relationship between Gini index and median expression level in tissues.(D) Distribution of Gini coefficients in the three classes of transcript in tissues.(E) Low-Gini PCBP1 expression in tissues.(F) Antibody-based assessment of the expression of SLC22A12 in a variety of tissues. Image edge length is 320 μm.

### Genes with Low Expression Profiles as Candidate "Housekeeping" Genes {#sec2.3.2}

A variety of genes have previously been proposed as housekeeping or reference genes ([@bib10], [@bib19], [@bib31], [@bib36], [@bib55], [@bib68], [@bib69], [@bib82], [@bib85], [@bib91], [@bib92], [@bib96]).

However, the expression of most so-called housekeeping genes (that are at least *expressed* in all tissues) actually varies quite widely between tissues (e.g., [@bib19], [@bib23], [@bib52], [@bib78]); indeed they are sufficiently different that they can be used to classify different tissues ([@bib38])! Here, the housekeeping genes with the lowest GCs, hence those possibly best for normalizing transcriptome or proteome experiment, are FAM32A (an RNA-binding protein; GC = 0.137), ABCB7 (a mitochondrial heme/iron exporter; GC = 0.137), MRPL16 and MRPL21 (mitoribosomal proteins; GC = 0.138), and PCBP1 (an oligo-single-stranded-dC-binding protein; GC = 0.139). Clearly their ubiquitous distribution speaks to their essentiality, and it is certainly of interest that mitoribosomal proteins have such ubiquitous expression, being somewhat equivalent to the 16S rRNA genes widely used in microbial taxonomy and metagenomics. Most of the other 49 large (MRPLxx) and 30 small (MRPSxx) ribosomal protein subunits also had low GCs; others with a GC of 0.15 or below are illustrated in [Figure 6](#fig6){ref-type="fig"}B, which also serves to show that most low-Gini gene products have median expression levels in the decade 20--200 TPM (so it is not a strange low-expression artifact).

We note that [@bib24] provide a list of candidate housekeeping genes based on earlier RNA sequencing data. This provides a valuable benchmark for comparison with our approach. However, their list (see [http://www.tau.ac.il/∼elieis/HKG/HK_genes.txt](http://www.tau.ac.il/%7Eelieis/HKG/HK_genes.txt){#intref0020}) consists of no fewer than 3,804 genes (out of the ∼25,000 human genes), but provides no quantification of either how good they are as housekeeping/reference genes or of their typical expression levels. Finding the best 6 or 7 out of such an unranked list of 3,804 is a combinatorial problem that would require testing 4.10^18^ or 2.10^21^ combinations, respectively. By contrast we provide *both* the rank order (*and* its justification via the Gini index) *and* the transcription level. Secondly, the paper itself ([@bib24]) used only 16 (not, as here, 59) tissues, and *no* cell lines. Thirdly, the paper does contain a Table of eleven "genes proposed for calibration", representing (on an unstated basis) "a short list of highly uniform and strongly expressed genes that may be used for calibration in future experimental settings"; [Table S3](#mmc1){ref-type="supplementary-material"} lists these, together with their correct names, UniProt ID, and (from our data) Gini index and median tissue expression levels.

It is rather obvious ([Table S3](#mmc1){ref-type="supplementary-material"}) that the choices in this Table are far poorer than those we suggest in terms of both GC (only one has a GC below 0.15 \[for tissues we show 23\] [Figure 6](#fig6){ref-type="fig"}B) and expression level (e.g., PCBP1 has a GC of 0.139 and an expression level of 209 TPM in tissues).

Indeed, the GCs of other gene products commonly used by experimental biologists to normalize expression profiles were often considerably larger ([Table S4](#mmc1){ref-type="supplementary-material"}), although the more recently proposed *CTBP1* (C-terminal-binding protein 1, UniProt [Q13363](uniprotkb:Q13363){#intref0025}; 0.204) and GOLGA1 (Golgin subfamily A member 1, UniProt [Q92805](uniprotkb:Q92805){#intref0030}; 0.189) ([@bib53]) both seem like much better choices. However, the lowest GCs in tissues are FAM32A, ABCB7, MRPL21, and PCBP1 (GC = 0.137--0.139), while the lowest three in cell lines are SF3B2, NXF1, and RBM45 (GC = 0.115--0.122). PCBP1 is both reasonably highly expressed and has a low GC in both tissues (0.139) and cell lines (0.135), and is an excellent novel housekeeping gene. While reference genes are often chosen to be stably expressed across variants of the same cell type rather than across different cells, our very low GC *between* cell types suggests that the GC is indeed a novel and effective way of identifying very useful housekeeping or reference genes in expression profiling studies.

While there was no relationship between the GC and the maximum expression (not shown), there was an interesting inverse relationship between the GC and the median expression level over all genes ([Figure 6](#fig6){ref-type="fig"}C), where the correlation coefficient was 0.62. Clearly the exact correlation is also likely to depend on the value of the GC, where at higher levels the Lorenz curve ([Figure 1](#fig1){ref-type="fig"}) can become highly nonlinear. The overall distribution of GCs for the three classes of protein (SLC/ABC/other) is given in [Figure 6](#fig6){ref-type="fig"}D. Finally, because it was one of the gene products with the lowest GC, as well as having a reasonable expression level (median over 100 TPM), in both tissues and cell lines, we show the tissue expression profile of PCBP1 (an intronless gene; [@bib58]) in [Figure 6](#fig6){ref-type="fig"}E; the overall variation of the great majority of these transcripts is within a 2-fold range. We also illustrate its distribution in several tissues in [Figure 6](#fig6){ref-type="fig"}F. This makes a very strong case for it being a highly useful reference or housekeeping gene.

### Cell Lines {#sec2.3.3}

The overall data are broadly similar for cell lines ([Figure 7](#fig7){ref-type="fig"}A, although the expression of zinc fingers is less homogeneous than in the tissues). However, the genes with the lowest GC ([Figure 7](#fig7){ref-type="fig"}B) are mostly very different from those in tissues. Note that SLC4A1AP that appears is an adaptor protein for SLC4A1 (a chloride-bicarbonate exchanger, commonly known as band 3 protein), so it is not itself a true SLC (and it did not appear in [Figure 3](#fig3){ref-type="fig"}B). The gene whose expression showed the very lowest GC, *SF3B2* (UniProt [Q13435](uniprotkb:Q13435){#intref0035}), is a subunit of an RNA splicing factor, while NXF1 (UniProt [Q9UBU9](uniprotkb:Q9UBU9){#intref0040}) is a nuclear export factor, and RBM45 (UniProt [Q8IUH3](uniprotkb:Q8IUH3){#intref0045}) an RNA binding protein 45. It is entirely reasonable that these might be expressed in all cells, and evidently at a fairly constant level. Overall, we conclude that the GeneGini approach is capable of finding novel housekeeping genes to act as references for microarrays and for qPCR, and will be particularly beneficial in studies employing several differentiated cell/tissue types. There is again a correlation between the Gini index and median expression level (r^2^ = 0.67) ([Figure 7](#fig7){ref-type="fig"}C). Overall, we find that 8.5% of SLCs, 16% of ABCs (including two F-family members), and 18% of other genes have a GC below 0.25, while those above 0.75 are ABC 32%, SLC 25%, and other 19%. Again, there is a significantly greater heterogeneity among transporter genes than among other genes when taken as a whole ([Figure 7](#fig7){ref-type="fig"}D). Finally, [Figure 7](#fig7){ref-type="fig"}E shows the expression profile of PCBP1 in cell lines; again the overwhelming majority is within a 2-fold range, indicating its excellent candidature as a novel reference gene.Figure 7Variation of Gini Coefficients of Different Protein Classes in 56 Cell Lines(A) All transcripts, alphabetically, in cell lines.(B) Transcripts with a particularly low Gini coefficient in cell lines.(C) Inverse relationship between Gini index and median expression level in cell lines.(D) Distribution in cell lines of Gini coefficients in the three classes.(E) PCBP1 expression in different cell lines.

Discussion {#sec2.4}
----------

The present paper has highlighted at least three main areas. First, we exploit the GC as a novel, convenient, and easily understandable metric for reflecting how unequally a given transcript is expressed in a large series of tissues or cell lines. In contrast to its usual use in economics, where it ranges from ∼0.25 to ∼0.51 in different countries, the Gini index here ranged from as low as 0.11 to as high as 0.98, reflecting in the latter case virtually unique expression in a particular tissue. In many cases, the biology underpinning this is quite opaque, but the purpose of data-driven studies is to generate rather than to test hypotheses ([@bib45]). We also recognize here that we have paid relatively little attention to the distribution of transporters *within* different tissues and their potential cell-type-specific distribution within an organ (e.g., [@bib3]), where they presumably account for the very striking intra-organ distributions of drugs (e.g., [@bib79]); that will have to be a subject for further work.

A second chief area of interest is the distribution of transporters between different tissues. A detailed analysis showed that they tended to have significantly higher GCs than did other gene families. This illustrates the point that despite the fact that their substrates are almost uniformly available via the bloodstream, and biochemistry textbooks and wallcharts largely show this, they clearly use substrates differentially (ergothioneine and the SLC22A4 transporter being a nice example; [@bib30]). It also implies strongly that in many cases we do not in fact know the natural substrates, many of which are clearly exogenous ([@bib64]).

The third main recognition is that the Gini index provides a particularly useful, convenient, non-parametric, and intelligible means of identifying those genes whose expression profile varies least across a series of cells or tissues, thus providing a novel and convenient strategy for the identification of those reference or housekeeping genes best used as genes against which to normalize other expression profiles in a variety of studies. We have here highlighted quite a number that have not previously been so identified.

Overall, we consider that assessing the Gini index for the distribution of particular transporters and other proteins between different cells has much to offer the development of novel biology; it should prove a highly useful addition to the armory of both the systems biologist and the data analyst.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Software and Algorithms**Gini coefficient[https://CRAN.R-project.org/package=ineq](https://cran.r-project.org/package=ineq){#intref0050}**RESOURCE: Cell Atlas, cell line RNA-seq data**Human Protein Atlas<https://www.proteinatlas.org/download/rna_celline.tsv.zip>**RESOURCE: Tissue Atlas, tissue RNA-seq data**Human Protein Atlas<https://www.proteinatlas.org/download/rna_tissue.tsv.zip>

Contact for Reagent and Resource Sharing {#sec3.2}
----------------------------------------

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Douglas B. Kell (<dbk@manchester.ac.uk>).

Method Details {#sec3.3}
--------------

The expression profile data are not new; the means by which they were obtained is described elsewhere ([@bib86], [@bib90]). mRNA sequencing was performed on Illumina HiSeq2000 and 2,500 platforms (Illumina, San Diego, CA, USA) using the standard Illumina RNA-seq protocol with a read length of 2x100 bases. Transcript abundance estimation was performed using Kallisto ([@bib6]) v0.42.4. For each gene, we report the abundance in \'Transcripts Per Million\' (TPM) as the sum of the TPM values of all its protein-coding transcripts. For each cell line and tissue type, the average TPM values for replicate samples were used as abundance score. Thus each transcript level does represent an absolute value, but it is then normalised to the total expression in the particular sample. The data were extracted and extended in the form of Microsoft Excel sheets (Raw SLC and ABC data in [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}).

Most of the analyses are self-explanatory, but are noted below. As in many of our cheminformatics analyses (e.g. ([@bib63], [@bib67])) we used the freely available KNIME software environment ([@bib5], [@bib62], [@bib67]) (<http://knime.org/>), with visualisation often provided via the Tibco Spotfire software (Perkin-Elmer Informatics).

### Gini Index {#sec3.3.1}

The Gini Index was calculated using the **ineq** package (Achim Zeileis (2014). ineq: Measuring Inequality, Concentration, and Poverty. R package version 0.2-13. [https://CRAN.R-project.org/package=ineq](https://cran.r-project.org/package=ineq){#intref0075}) in **R** ([https://www.R-project.org/](https://www.r-project.org/){#intref0080}). These calculations were incorporated into KNIME via KNIME's R integration *R Snippet* node. The Rank Correlation used was Spearman's rho, using the KNIME *Rank Correlation node*.

### Minimum and Maximum Expression Profiles {#sec3.3.2}

These and the other similar analyses were done using the functions contained in MS-Excel.

#### Immunohistochemistry {#sec3.3.2.1}

Immunohistochemical (IHC) images detailing protein expression patterns in 48 different normal tissues and 20 common cancer types are from the Human Protein Atlas database ([www.proteinatlas.org](http://www.proteinatlas.org){#intref0085}). Tissue microarrays, immunostaining and image evaluation was performed as previously described ([@bib90]). Briefly, 1mm duplicate cores were used for immunostaining using the following antibodies: HPA024575 for SLC22A12, HPA011885 for SLC6A18, HPA006539 for SLC2A14 (all from the Human Protein Atlas) and CAB037113 for PCBP1 (R1455 from Sigma-Aldrich). The immunostaining intensity and pattern was manually evaluated and scored by certified pathologists.

Quantification and Statistical Analysis {#sec3.4}
---------------------------------------

For each cell line and tissue type, the average TPM values for replicate samples were used as abundance score.

Data and Software Availability {#sec3.5}
------------------------------

The data on which we base our analyses are all available online at <https://www.proteinatlas.org/about/download> (and see [Key Resources Table](#sec3.1){ref-type="sec"}).
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